[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Benef](https://github.com/mm80843/T3.5/tree/main/docs/Benef/index.md) >> Individual ID:PBN__Benef_1189 

# __Reduction of hospital acquired infections__

## Articles mentionning this Benefit

* [A Continuously Active Antimicrobial Coating effective against Human Coronavirus 229E](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_246.md)

## Category to which it belongs

* [Effective control and elimination of infectious pathogens to prevent disease transmission and reduce the overall risk of infection.](https://github.com/mm80843/T3.5/blob/pages/PBNCategory/PBN__PBNCategory_1.md)

## Description of actual returns pertaining to this benefit

* [Reduced healthcare costs, improved patient outcomes, increased asset value through reputation and patient satisfaction](https://github.com/mm80843/T3.5/blob/pages/BenefReturn/PBN__BenefReturn_1328.md)

## Name of the Benefit

Continuously active antimicrobial coating reduces the spread of hospital acquired infections in clinical settings

## Risks which can benefit from this action

* [Continuously active antimicrobial coating](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_1189.md)

## Stakeholders benefitting from this Benefit

* [Hospitals](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_31.md)
* [Patients](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_64.md)

